2.23 (-%)
As of Nov 01, 2024
Source:
We are a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in inflammatory diseases and oncology. Utilizing our proprietary drug discovery and development engine, we are developing highly selective small molecules designed to modulate the critical immune responses underlying these diseases.
Country | United States |
Headquarters | south san francisco, california |
Phone Number | (650) 489-9000 |
Industry | manufacturing |
CEO | Brian Wong |
Website | rapt.com |